Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents.
about
Tuberculosis vaccines and prevention of infectionTuberculosis in patients with haematological malignancies.Decreasing household contribution to TB transmission with age: a retrospective geographic analysis of young people in a South African townshipIn vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.Tuberculin skin test and interferon-gamma release assay values are associated with antimicrobial peptides expression in polymorphonuclear cells during latent tuberculous infection.The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community.TB incidence in an adolescent cohort in South AfricaQuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study.The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.A Subgroup of Latently Mycobacterium tuberculosis Infected Individuals Is Characterized by Consistently Elevated IgA Responses to Several Mycobacterial Antigens.Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the EvidenceHIV-1 and the immune response to TB.Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults.Update in tuberculosis and nontuberculous mycobacterial disease 2012.T cells and adaptive immunity to Mycobacterium tuberculosis in humans.Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.A review of clinical models for the evaluation of human TB vaccines.T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts.Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country.Detecting New Mycobacterium tuberculosis Infection. Time for a More Nuanced Interpretation of QuantiFERON Conversions.Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong.Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing.Risk of tuberculosis among QuantiFERON converters and nonconverters.Quantiferon TB-Gold conversion can predict active tuberculosis development in elderly nursing home residents.Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
P2860
Q26782022-C4DBAD24-B394-4F1A-B970-595B7B913649Q33568467-1993B434-9184-4CF6-A46C-83534C135F4DQ33574194-F6A69B45-92A1-4B47-BFB3-91EBE3C7132BQ33824247-7BB8FA72-7107-4789-B10F-9A382A641176Q34040593-551E1195-90C9-4CD4-9F9A-F7A3151F1489Q34489446-DED2F8C9-0EE0-4E53-B584-A766D08C67EBQ34637907-FC1195BF-AFCF-445A-B901-03596E6E943CQ34686071-6C7AD613-C2D9-40A6-9AA4-7D5ECC46E2E1Q35261953-FE8B2803-1F85-40A3-A50D-511908F62072Q35988987-9EE135A9-34F3-4567-A5B1-EBA4B6FE5B2DQ36197198-74D40D36-3672-48AD-90B4-6E3E188D9F60Q36637982-CED2922A-DA2C-4C51-A897-78F34609AB18Q36815449-656358CB-51D0-458D-AB5E-5C083EE4C106Q37304401-A38A08DD-A9F6-4E70-A2BF-336A05F705D4Q37510309-4698DDFA-34F5-4843-A36A-8F4AE46A6076Q37544916-0652C352-1A51-486D-93B0-EFE713B93854Q38069419-803017BB-C0E8-4492-9D67-4995ACF971FDQ38152788-43C78F1A-549C-496A-B9EF-58F885F046BDQ38363792-A76C9A8E-1A0F-4C53-8B61-CCDF53322A09Q38664922-7E4BEE0B-92FE-4AE7-82E4-BF429F1D4098Q38711772-7F5A1507-21F1-4DA7-891B-90E89264D642Q39037917-F27B8A28-53E9-4FE7-99B3-C107214AFE93Q39875966-D45A7256-DBBF-42E5-A504-4B0A0FA12C3BQ40099727-838A1AA7-6553-4419-9A60-A2015A97D075Q40696371-A4CD8F30-9818-4ACA-BB29-867EB4CC65B4Q41473597-F9D73EDA-3BAB-4C18-B3BE-4C4B1E4A4BA4Q46252828-E8CFCCC2-F761-40E1-A72C-37C0411A809FQ48154595-9E689192-43C5-49D4-B766-F2D552197E7EQ55617820-B4C1B3ED-0D55-45E2-906F-03D4392DC2D5
P2860
Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Predictive value of recent Qua ...... ulosis disease in adolescents.
@en
Predictive value of recent Qua ...... ulosis disease in adolescents.
@nl
type
label
Predictive value of recent Qua ...... ulosis disease in adolescents.
@en
Predictive value of recent Qua ...... ulosis disease in adolescents.
@nl
prefLabel
Predictive value of recent Qua ...... ulosis disease in adolescents.
@en
Predictive value of recent Qua ...... ulosis disease in adolescents.
@nl
P2093
P2860
P50
P1476
Predictive value of recent Qua ...... ulosis disease in adolescents.
@en
P2093
Deborah-Ann Abrahams
Hassan Mahomed
Humphrey Mulenga
Shingai Machingaidze
Suzanne Verver
P2860
P304
P356
10.1164/RCCM.201206-1134OC
P407
P577
2012-09-06T00:00:00Z